Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COOPER COMPANIES, INC.COO · Entity 3395 | Director | January 06, 2023 | January 10, 2023 |
| PDL BIOPHARMA, INC.PDLI · Entity 143144 | Director | June 08, 2018 | June 12, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COOPER COMPANIES, INC.
Report date January 06, 2023 · Filed January 10, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectMatthews-Lindell Family Trust, dated July 23, 1991, as amended and restated | 14,543 |
Reported balance
After 2023-01-06 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2023-01-06 · Exercise / conversion · Acquired 1,000 · Balance 14,543 |
| Common StockSEC Table I · non-derivative | IndirectMatthews-Lindell Family Trust, dated July 23, 1991, as amended and restated | 13,543 |
Reported balance
After 2023-01-06 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2023-01-06 · Sale · Disposed 1,000 · Balance 13,543 F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $344.24 to $344.505. The reporting person undertakes to provide The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $128.35 · Expires 2023-11-01 | IndirectMatthews-Lindell Family Trust, dated July 23, 1991, as amended and restated | 2,227 |
Reported balance
After 2023-01-06 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-01-06 · Exercise / conversion · Disposed 1,000 · Balance 2,227 |
| Common StockSEC Table I · non-derivative | IndirectJody S. Lindell Separate Property Trust | 6,250 |
Reported balance
Holding disclosure · report date 2023-01-06 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 6,250 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $344.24 to $344.505. The reporting person undertakes to provide The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.
PDL BIOPHARMA, INC.
Report date June 08, 2018 · Filed June 12, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 256,174 |
Reported balance
After 2018-06-08 transaction · row 1
1 source rowRow 1 · 2018-06-08 · Grant · Acquired 54,348 · Balance 256,174 F1: The grant will cliff-vest on the first anniversary of the date of grant so long as the grant recipient continues to serve on the Board of Directors of PDL BioPharma, Inc. |
Filing footnotes · ownership attribution and instrument terms
F1: The grant will cliff-vest on the first anniversary of the date of grant so long as the grant recipient continues to serve on the Board of Directors of PDL BioPharma, Inc.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 28, 2018 Filed Dec 11, 2018 23:18 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | GiftRestricted Stock Units · Derivative | 437 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-035932 · form4.xml · derivative · entry 5 Lindell Jody S · CIK 0001356151 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Matthews-Lindell Family Trust, dated July 23, 1991 as amended and restated Disclosed balance after: 437 Underlying: Common Stock · 437 shares Expires not disclosed F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F1 · price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F2 · derivative.exercise_date: NED (prorated) RSU Grant 11/15/18: RSUs will vest and release on April 1, 2019. F3 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| November 28, 2018 Filed Dec 11, 2018 23:18 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | GiftRestricted Stock Units · Derivative | 437 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-035932 · form4.xml · derivative · entry 4 Lindell Jody S · CIK 0001356151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 437 shares Expires not disclosed F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F1 · price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F2 · derivative.exercise_date: NED (prorated) RSU Grant 11/15/18: RSUs will vest and release on April 1, 2019. F3 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| November 15, 2018 Filed Nov 16, 2018 21:18 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionRestricted Stock Units · Derivative | 1,151 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-033412 · form4.xml · derivative · entry 6 Lindell Jody S · CIK 0001356151 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Matthews-Lindell Family Trust, dated July 23, 1991 as amended and restated Disclosed balance after: 0 Underlying: Common Stock · 1,151 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F4 · derivative.exercise_date: NED RSU Grant 11/15/17: RSUs will vest and release on the first anniversary of the date of grant 11/15/2018. F3 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| November 15, 2018 Filed Nov 16, 2018 21:18 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | GrantRestricted Stock Units · Derivative | 437 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-033412 · form4.xml · derivative · entry 5 Lindell Jody S · CIK 0001356151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 437 Underlying: Common Stock · 437 shares Expires not disclosed F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F2 · derivative.exercise_date: NED (prorated) RSU Grant 11/15/18: RSUs will vest and release on April 1, 2019. F3 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| November 15, 2018 Filed Nov 16, 2018 21:18 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionCommon Stock | 1,151 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-033412 · form4.xml · nonDerivative · entry 1 Lindell Jody S · CIK 0001356151 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Matthews-Lindell Family Trust, dated July 23, 1991 as amended and restated Disclosed balance after: 12,554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2018 Filed Jun 12, 2018 20:30 UTC | PDL BIOPHARMA, INC. PDLI · Entity 143144 | GrantCommon stock | 54,348 | $2.76 | $150,000.48 |
DisclosureSEC source: 0000882104-18-000068 · wf-form4_152883539902271.xml · nonDerivative · entry 1 Lindell Jody S · CIK 0001356151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,174 F1 · shares: The grant will cliff-vest on the first anniversary of the date of grant so long as the grant recipient continues to serve on the Board of Directors of PDL BioPharma, Inc. Read SEC document |
| December 05, 2017 Filed Dec 14, 2017 22:41 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | GiftRestricted Stock Units · Derivative | 1,151 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-034722 · form4.xml · derivative · entry 5 Lindell Jody S · CIK 0001356151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,151 shares Expires not disclosed F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F2 · derivative.exercise_date: NED RSU Grant 11/15/17: RSUs will vest and release on the first anniversary of the date of grant 11/15/2018. F3 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| December 05, 2017 Filed Dec 14, 2017 22:41 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | GiftRestricted Stock Units · Derivative | 1,151 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-034722 · form4.xml · derivative · entry 4 Lindell Jody S · CIK 0001356151 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Matthews-Lindell Family Trust, dated July 23, 1991 as amended and restated Disclosed balance after: 1,151 Underlying: Common Stock · 1,151 shares Expires not disclosed F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F2 · derivative.exercise_date: NED RSU Grant 11/15/17: RSUs will vest and release on the first anniversary of the date of grant 11/15/2018. F3 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| November 15, 2017 Filed Nov 16, 2017 23:16 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | GrantRestricted Stock Units · Derivative | 1,151 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-032454 · form4.xml · derivative · entry 6 Lindell Jody S · CIK 0001356151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,151 Underlying: Common Stock · 1,151 shares Expires not disclosed F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F4 · derivative.exercise_date: NED RSU Grant 11/15/17: RSUs will vest and release on the first anniversary of the date of grant, 11/15/2018. F3 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| November 15, 2017 Filed Nov 16, 2017 23:16 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionRestricted Stock Units · Derivative | 1,570 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-032454 · form4.xml · derivative · entry 5 Lindell Jody S · CIK 0001356151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,570 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F1 · price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F2 · derivative.exercise_date: NED RSU Grant 11/15/16: RSUs will vest and release on the first anniversary of the date of grant 11/15/2017. F3 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| November 15, 2017 Filed Nov 16, 2017 23:16 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionCommon Stock | 1,570 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-032454 · form4.xml · nonDerivative · entry 1 Lindell Jody S · CIK 0001356151 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Matthews-Lindell Family Trust, dated July 23, 1991 as amended and restated Disclosed balance after: 11,403 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 00:19 UTC | PDL BIOPHARMA, INC. PDLI · Entity 143144 | GrantCommon stock | 60,729 | $2.47 | $150,000.63 |
DisclosureSEC source: 0000882104-17-000064 · wf-form4_149731314782614.xml · nonDerivative · entry 1 Lindell Jody S · CIK 0001356151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,826 F1 · shares: The grant will cliff-vest on the first anniversary of the date of grant so long as the grant recipient continues to serve on the Board of Directors of PDL BioPharma, Inc. During the one-year vesting period, the grant recipient will have the right to vote the shares and receive any dividends and other distributions paid, except that dividends and other distributions will be accumulated and will vest and be paid, with interest, on the earlier of the same vesting conditions as the original award or March 15th of the year following the payment of such dividend or distribution to all stockholders. Read SEC document |
| March 14, 2017 Filed Mar 15, 2017 21:12 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionNon-employee Director Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $13.08 | $0.00 |
DisclosureSEC source: 0001127602-17-011808 · form4.xml · derivative · entry 6 Lindell Jody S · CIK 0001356151 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Matthews-Lindell Family Trust, dated July 23, 1991 as amended and restated Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2018-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2017 Filed Mar 15, 2017 21:12 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | SaleCommon Stock | 5,000 | $193.38 | $966,915.50 |
DisclosureSEC source: 0001127602-17-011808 · form4.xml · nonDerivative · entry 2 Lindell Jody S · CIK 0001356151 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Matthews-Lindell Family Trust, dated July 23, 1991 as amended and restated Disclosed balance after: 9,833 F1 · price: The sale price represents an average sales price between $193.38 and $193.429. Read SEC document |
| March 14, 2017 Filed Mar 15, 2017 21:12 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionCommon Stock | 5,000 | $13.08 | $65,400.00 |
DisclosureSEC source: 0001127602-17-011808 · form4.xml · nonDerivative · entry 1 Lindell Jody S · CIK 0001356151 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Matthews-Lindell Family Trust, dated July 23, 1991 as amended and restated Disclosed balance after: 14,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2017 Filed Mar 9, 2017 00:59 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionNon-employee Director Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $13.08 | $0.00 |
DisclosureSEC source: 0001127602-17-010951 · form4.xml · derivative · entry 7 Lindell Jody S · CIK 0001356151 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Matthews-Lindell Family Trust, dated July 23, 1991 as amended and restated Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2018-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2017 Filed Mar 9, 2017 00:59 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | SaleCommon Stock | 720 | $194.36 | $139,939.20 |
DisclosureSEC source: 0001127602-17-010951 · form4.xml · nonDerivative · entry 3 Lindell Jody S · CIK 0001356151 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Matthews-Lindell Family Trust, dated July 23, 1991 as amended and restated Disclosed balance after: 9,833 F2 · price: The sale price represents an average of sale prices between $194.2650 and $194.4500. Read SEC document |
| March 07, 2017 Filed Mar 9, 2017 00:59 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | SaleCommon Stock | 4,280 | $193.75 | $829,250.00 |
DisclosureSEC source: 0001127602-17-010951 · form4.xml · nonDerivative · entry 2 Lindell Jody S · CIK 0001356151 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Matthews-Lindell Family Trust, dated July 23, 1991 as amended and restated Disclosed balance after: 10,553 F1 · price: The sale price represents an average of sale prices between $193.2000 and $194.1950. Read SEC document |
| March 07, 2017 Filed Mar 9, 2017 00:59 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | Exercise / conversionCommon Stock | 5,000 | $13.08 | $65,400.00 |
DisclosureSEC source: 0001127602-17-010951 · form4.xml · nonDerivative · entry 1 Lindell Jody S · CIK 0001356151 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Matthews-Lindell Family Trust, dated July 23, 1991 as amended and restated Disclosed balance after: 14,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2016 Filed Nov 16, 2017 23:16 UTC | COOPER COMPANIES, INC. COO · Entity 3395 | GrantRestricted Stock Units · Derivative | 1,570 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-032454 · form4.xml · derivative · entry 4 Lindell Jody S · CIK 0001356151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,570 Underlying: Common Stock · 1,570 shares Expires not disclosed F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F2 · derivative.exercise_date: NED RSU Grant 11/15/16: RSUs will vest and release on the first anniversary of the date of grant 11/15/2017. F3 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.